Indeed, a mutant p53 can acquire the ability to both positively and negatively regulate gene expression, which clearly contributes to some of the pro-tumorigenic functions of a mutant p53, such as enhanced survival and resistance to cancer therapy [16,47]. The gene discussed is TP53; the disease is cancer.